FINORA Nutra exists because the nutraceutical industry asks people to trust claims it rarely proves. Dosages rounded down for margin. Actives hidden inside proprietary blends. Certificates of analysis promised but seldom published. We built the opposite — a nutraceutical company that publishes assay data by lot, sets doses to what the studies used, and grades the evidence behind every formulation in plain view.
FINORA Nutra is one of several ventures operating under the FINORA Group umbrella. Sibling ventures include FINORA AgroScience and FINORA Unlock, each in its own domain, each held to the same institutional standard for quality, documentation, and accountability. FINORA Nutra is the group's nutraceuticals arm, operated commercially by FINORA Trading LLC, an Albuquerque, New Mexico entity.
Sibling ventures are separate operating units with their own product roadmaps; this page describes only FINORA Nutra.
Each new formulation is drafted against the published literature — the specific studies that establish efficacy for the intended use, the doses those studies used, and the delivery forms with the best absorption evidence. Nothing enters development on trend alone.
The FINORA Scientific Advisory Board — practitioners and researchers in nutritional biochemistry, clinical pharmacy, and analytical chemistry — reviews the formulation, dose rationale, evidence grade, and safety profile before a manufacturing spec is issued.
Once a lot is produced, third-party assays for potency, identity, and heavy metals are verified against the formulation spec. A lot only releases when the certificate of analysis matches the label — no rounding, no exceptions.
We describe our Scientific Advisory Board as a governance process rather than as a marquee of named experts. Named advisor bios will be published on this page as the board is finalized and each member consents to public attribution. We would rather publish nothing than publish invented credentials.
We source raw materials from suppliers who can produce a full identity, potency, and contaminant certificate of analysis on the specific lot we buy. Suppliers who cannot are declined — regardless of price advantage.
Amber glass primary packaging for oxygen- and light-sensitive actives. We are actively moving away from unnecessary secondary plastic and toward recyclable, minimum-material outer packaging on new SKUs.
No health claims that outrun the evidence grade of the formulation. No fabricated endorsements. No before/after imagery. If a study is preliminary, we say so, and we grade it accordingly.
Customer data collected through this site (contact forms, newsletter signups) is used only to respond to enquiries and provide requested information. We do not sell customer data. See our privacy policy for detail.
These are stated as commitments and direction of travel, not as completed certifications. Where we hold specific third-party certifications, they are listed on the individual product pages and on our Quality page.
Our Quality page documents the full sequence — supplier audit, in-process controls, third-party assay, batch verification.
Read our Quality process →